INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,897,200 | -22.5% | 60,000 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $2,446,800 | +4.2% | 60,000 | -4.8% | 0.01% | 0.0% |
| Q1 2023 | $2,348,010 | -74.4% | 63,000 | -76.0% | 0.01% | -77.3% |
| Q4 2022 | $9,176,070 | -49.5% | 263,000 | -19.1% | 0.02% | -51.1% |
| Q3 2022 | $18,187,000 | +99.7% | 325,000 | +84.7% | 0.04% | +114.3% |
| Q2 2022 | $9,109,000 | -26.7% | 175,978 | +2.9% | 0.02% | -12.5% |
| Q1 2022 | $12,425,000 | -85.4% | 170,978 | -76.2% | 0.02% | -84.3% |
| Q4 2021 | $84,835,000 | -11.9% | 717,478 | 0.0% | 0.15% | -19.5% |
| Q3 2021 | $96,250,000 | +28.4% | 717,478 | +55.0% | 0.19% | +29.3% |
| Q2 2021 | $74,961,000 | – | 462,978 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |